Minoxidil 2% vs 5%: Which Is More Effective?
This is a research-based fact check, not medical advice. The findings summarized here come from peer-reviewed studies and are presented without added opinions. Consult a certified healthcare practitioner before making any treatment decision.
Verdict
5% minoxidil is significantly more effective than 2% minoxidil for hair regrowth. In a 48-week trial of 393 men, 5% produced 45% more hair regrowth than 2% as measured by nonvellus hair count (18.6 vs 12.7 hairs added in the target area). Response to 5% also occurred faster. The trade-off is a higher rate of scalp irritation, due to the higher propylene glycol content of the 5% solution. For women, 5% foam is now also approved and produces comparable efficacy with lower irritation.
Key takeaways
- 5% minoxidil produced 45% more hair regrowth than 2% in a 48-week controlled trial (18.6 vs 12.7 nonvellus hairs added).
- 5% was superior to 2% on 4 out of 6 efficacy measures in the same trial.
- Response to 5% also occurred faster than response to 2% in the same trial.
- 5% solution causes more scalp irritation than 2%, due to higher propylene glycol content.
- 5% foam avoids the irritation trade-off by removing propylene glycol from the vehicle.
- Both concentrations are FDA-approved for men; women are approved for 2% solution and 5% foam.
What the clinical trial shows
The key head-to-head comparison of 2% vs 5% minoxidil comes from the Olsen 2002 trial: a 48-week, double-blind, placebo-controlled trial of 393 men with pattern hair loss. This is the foundational study for the 5% vs 2% comparison and the basis for FDA approval of the higher concentration. For broader context on hair loss treatment options, see the hair restoration guide.
Hair count data showed that 5% minoxidil added 18.6 nonvellus hairs in the target area over 48 weeks, compared to 12.7 hairs for 2% minoxidil a difference of 45%. 5% was superior to 2% on 4 of 6 efficacy measures and superior to placebo on all 6. Both concentrations outperformed placebo. Response also occurred earlier with 5% than with 2%, as measured by hair count data at interim time points.
Side effect trade-off
The higher efficacy of 5% comes with a higher rate of scalp irritation. This is primarily because the 5% solution contains a higher concentration of propylene glycol, the vehicle ingredient responsible for most local irritation and contact reactions. In the Olsen 2002 trial, increased pruritus (itching) and local irritation were observed more frequently with 5% than 2%.
The development of 5% minoxidil foam addressed this trade-off by removing propylene glycol from the vehicle. Clinical data shows the 5% foam produces similar hair count improvements to the 5% solution, but with significantly lower rates of scalp irritation. For patients who cannot tolerate the 5% solution, switching to 5% foam is typically preferable to dropping to 2% solution.
Approved uses for men and women
For men, both 2% solution (twice daily) and 5% solution (twice daily) are FDA-approved, as is 5% foam (once daily). The higher concentration is now the more commonly recommended starting point for men. For women, 2% solution (twice daily) and 5% foam (once daily) are FDA-approved. The 5% solution is not specifically approved for women. Unwanted facial hair growth (hypertrichosis) occurs at higher rates in women than men at equivalent concentrations, which affects the concentration choice.
Which concentration to choose
For men who can tolerate scalp application without significant irritation, the evidence supports starting with 5% rather than 2%. The efficacy advantage is meaningful. For patients who experience irritation on the 5% solution, switching to 5% foam rather than downgrading to 2% solution preserves the efficacy advantage while removing the primary irritant. For women, 5% foam is appropriate for most patients; 2% solution is a reasonable choice for those with sensitive skin or higher concern about hypertrichosis.
2% vs 5% at a glance
| Feature | 2% solution | 5% solution | 5% foam |
|---|---|---|---|
| Hair regrowth (48 wks, Olsen 2002) | 12.7 hairs added | 18.6 hairs added (45% more) | Similar to 5% solution |
| FDA approval (men) | Yes | Yes | Yes |
| FDA approval (women) | Yes (twice daily) | Not specifically | Yes (once daily) |
| Scalp irritation rate | ~7% | Higher (more PG) | Lower (no PG) |
| Application frequency | Twice daily | Twice daily | Once daily |
What the research cannot tell you
- Whether the 45% efficacy advantage of 5% vs 2% solution also applies when comparing 5% foam to 2% solution.
- Long-term outcomes beyond 48 weeks in a direct 2% vs 5% controlled comparison.
- Whether starting at 5% and later reducing to 2% maintains the initial gains.
- How the 2% vs 5% comparison applies to women (the Olsen 2002 trial enrolled only men).